Literature DB >> 16533710

Optimizing the use of open-source software applications in drug discovery.

Werner J Geldenhuys1, Kevin E Gaasch, Mark Watson, David D Allen, Cornelis J Van der Schyf.   

Abstract

Drug discovery is a time consuming and costly process. Recently, a trend towards the use of in silico computational chemistry and molecular modeling for computer-aided drug design has gained significant momentum. This review investigates the application of free and/or open-source software in the drug discovery process. Among the reviewed software programs are applications programmed in JAVA, Perl and Python, as well as resources including software libraries. These programs might be useful for cheminformatics approaches to drug discovery, including QSAR studies, energy minimization and docking studies in drug design endeavors. Furthermore, this review explores options for integrating available computer modeling open-source software applications in drug discovery programs.

Mesh:

Year:  2006        PMID: 16533710     DOI: 10.1016/S1359-6446(05)03692-5

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  12 in total

Review 1.  Computer-aided drug discovery and development (CADDD): in silico-chemico-biological approach.

Authors:  I M Kapetanovic
Journal:  Chem Biol Interact       Date:  2006-12-16       Impact factor: 5.192

Review 2.  What in silico molecular docking can do for the 'bench-working biologists'.

Authors:  Marius Mihăşan
Journal:  J Biosci       Date:  2012-12       Impact factor: 1.826

3.  MScreen: an integrated compound management and high-throughput screening data storage and analysis system.

Authors:  Renju T Jacob; Martha J Larsen; Scott D Larsen; Paul D Kirchhoff; David H Sherman; Richard R Neubig
Journal:  J Biomol Screen       Date:  2012-06-15

4.  Amelioration of C-Reactive Protein and Lectin Like Oxidized Low Density Lipoprotein Receptor Complex Induced Endothelial Dysfunction by Oligomeric Proanthocyanidins.

Authors:  Sankar Jamuna; Rathinavel Ashokkumar; Sivasitambaram Niranjali Devaraj
Journal:  Appl Biochem Biotechnol       Date:  2022-03-31       Impact factor: 2.926

5.  Open Data, Open Source and Open Standards in chemistry: The Blue Obelisk five years on.

Authors:  Noel M O'Boyle; Rajarshi Guha; Egon L Willighagen; Samuel E Adams; Jonathan Alvarsson; Jean-Claude Bradley; Igor V Filippov; Robert M Hanson; Marcus D Hanwell; Geoffrey R Hutchison; Craig A James; Nina Jeliazkova; Andrew Sid Lang; Karol M Langner; David C Lonie; Daniel M Lowe; Jérôme Pansanel; Dmitry Pavlov; Ola Spjuth; Christoph Steinbeck; Adam L Tenderholt; Kevin J Theisen; Peter Murray-Rust
Journal:  J Cheminform       Date:  2011-10-14       Impact factor: 5.514

6.  Understanding the foundations of the structural similarities between marketed drugs and endogenous human metabolites.

Authors:  Steve O'Hagan; Douglas B Kell
Journal:  Front Pharmacol       Date:  2015-05-13       Impact factor: 5.810

7.  Fragment-based docking: development of the CHARMMing Web user interface as a platform for computer-aided drug design.

Authors:  Yuri Pevzner; Emilie Frugier; Vinushka Schalk; Amedeo Caflisch; H Lee Woodcock
Journal:  J Chem Inf Model       Date:  2014-09-10       Impact factor: 4.956

8.  In silico studies for the interaction of tumor necrosis factor-alpha (TNF-α) with different saponins from Vietnamese ginseng (Panax vietnamesis).

Authors:  Oanh T P Kim; Manh D Le; Hoang X Trinh; Hai V Nong
Journal:  Biophys Physicobiol       Date:  2016-07-14

9.  Open access and open source in chemistry.

Authors:  Matthew H Todd
Journal:  Chem Cent J       Date:  2007-02-19       Impact factor: 4.215

10.  MS-DOCK: accurate multiple conformation generator and rigid docking protocol for multi-step virtual ligand screening.

Authors:  Nicolas Sauton; David Lagorce; Bruno O Villoutreix; Maria A Miteva
Journal:  BMC Bioinformatics       Date:  2008-04-10       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.